Interactive vision simulator illustrates the vision loss caused by retinal diseases
The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases
Retina community mourns sudden loss of Ramin Tadayoni, MD, PhD
Prof Tadayoni was a much-admired leader, researcher, surgeon and EURETINA President
Amniotic membrane could move the needle outside of the operating room
The tissue serves as a testing ground for outpatient ocular therapies
ASCRS 2024: MIGS data is outpacing "human intelligence," driving calls for AI
David Lubeck, MD, talks about the biggest surprises from ASCRS in the glaucoma space
Clinicians and researchers don’t shy away from hot topics in the field
The 15th annual Congress on Controversies in Ophthalmology heads to Athens, Greece
ASCRS 2024: Real-world results with an enhanced monovision toric lens
Josefina Botta, MD, MSc, discusses her real-world experiences with the RayOne EMV toric lens
ASCRS 2024: First-in-human data from Centricity Vision's ZEPTOLink IOL positioning system
The technology, which creates a 360-degree, instantaneous capsulotomy, appeared at the Eyecelerator event
I-SCREEN programme will use AI and OCT imaging to identify and monitor AMD
I-SCREEN will bring together 12 institutions across Europe, including Queen’s University Belfast
ASCRS 2024: Two papers demonstrate medication burden reduction and safety of a microcatheter for glaucoma
Dr Nir Shoham-Hazon presented two papers detailing outcomes from the iTrack microcatheter at ASCRS in Boston
ASCRS 2024: A case report on human corneal endothelial cell transplantation combined with cataract extraction and PCIOL
Elizabeth Yeu, MD, discusses a corneal case report at ASCRS 2024
ASCRS 2024: A retrospective study shows iStent's impact on medication burden in surgical and non-surgical patient groups
At ASCRS, Dr Rom Kandavel discusses iStent outcomes for patients who have undergone laser peripheral iridotomy, trabeculectomy and SLT
ASCRS 2024: Pearls of clinical and non-clinical wisdom for young eye surgeons
At this year's ASCRS meeting, J. Morgan Micheletti, MD, talks about his research and the Young Eye Surgeons (YES) programme
ASCRS 2024: IOLs, binocularity and stereoacuity in aperture optics
William F. Wiley, MD, shares key takeaways from his presentation on binocularity and stereoacuity
ASCRS 2024: Transforming how we think about IOL calculation with Light Adjustable Lens technology
Dr Neda Nikpoor discusses Light Adjustable Lenses and the implications for clinicians at ASCRS 2024
ASCRS 2024: International data are forthcoming in corneal endothelial disease treatment
At ASCRS 2024, Aurion Biotech's Global VP Eris Jordan previews upcoming clinical data from North America and Asia
ASCRS 2024: Comparing keratometry and total keratometry values in a large dataset
Jascha Wendelstein, MD, discusses the outcomes of a study comparing K and TK measurements
ASCRS 2024: What's new in the ESCRS IOL calculator?
At ASCRS 2024, Oliver Findl, MD, provides an update on the ESCRS IOL calculator and new tools to come this year
ASCRS 2024: At Eyecelerator, a New Zealand-based startup pitches eye drops for keratoconus
Ahead of the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment
ASCRS 2024: Surgical and pharmaceutical technology updates from Bausch + Lomb
At the 2024 ASCRS meeting, Anthony Wallace details the presentations and educational programmes from Bausch + Lomb
ASCRS 2024: Ease of opening arcuate incisions created with a dual pulse femtosecond laser
At the ASCRS meeting in Boston, Dan Tran, MD, details his presentation on incision quality and clinical outcomes of femtosecond laser
ASCRS 2024: 10-year results from a real-world study shed new light on glaucoma
At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma
ASCRS 2024: Ultra-low cylinder powered toric versus non-toric lenses in cataract surgery
Adam Muzychuk, MD, BSc, FRCSC, discusses his ASCRS 2024 presentation on toric lens use for patients with low astigmatism
ASCRS 2024: Enrollment begins in Canada for cell therapy trial, targeting corneal endothelial disease
Greg Kunst, CEO of Aurion Biotech, discusses AURN001, a novel cell therapy targeting corneal endothelial disease
ASCRS 2024: Key features of LASIK using an updated laser ablation algorithm for myopia and myopic astigmatism
At ASCRS2024, George O. Waring IV, MD, FACS, provides an overview of his presentation highlighting outcomes for LASIK performed using an updated laser ablation algorithm
Cataract surgery pre-treatment with miLoop: Shorter lensectomy time, less irrigation needed
Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting
ESCRS president Filomena Ribeiro invites ASCRS attendees to 'cataract Olympiad' after successful Refractive Day
Filomena Ribeiro, MD, PhD, FEBO, discusses her presentation on neuroadaptation following the ASCRS Refractive Day
ASCRS 2024: CoFi integrates with CareCredit and marks participation milestone for ophthalmologists and optometrists
Sean Hanlon, CEO of CoFi, details the patient and provider benefits of recent CareCredit integration
ASCRS 2024: New Phase III study results and near-future plans for Neurotech and NT-501
Rich Small, CEO of Neurotech Pharmaceuticals, provides an update on the months ahead for NT-501 encapsulated cell therapy
Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center
Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation
Evaluation of an enhanced monofocal intraocular lens
Three IOLs are evaluated in a randomised study
